# Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery

> **NCT00233974** · PHASE2 · COMPLETED · sponsor: **UNC Lineberger Comprehensive Cancer Center** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **PROCEDURE:** PET (positron emission tomography)

## Key facts

- **NCT ID:** NCT00233974
- **Lead sponsor:** UNC Lineberger Comprehensive Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2005-02
- **Final completion:** 2006-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2012-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00233974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00233974, "Molecular Marker Profiling of Axillary Lymph Nodes in Predicting Response in Patients With Locally Advanced or Metastatic Breast Cancer Who Are Undergoing Chemotherapy Followed By Surgery". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00233974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*